Daily Stock Analysis, CDXC, Chromadex Corp, priceseries

Chromadex Corp. Daily Stock Analysis
Stock Information
Open
3.06
Close
3.02
High
3.12
Low
3.00
Previous Close
3.06
Daily Price Gain
-0.04
YTD High
4.95
YTD High Date
May 10, 2019
YTD Low
2.82
YTD Low Date
Oct 10, 2019
YTD Price Change
-0.39
YTD Gain
-11.44%
52 Week High
4.95
52 Week High Date
May 10, 2019
52 Week Low
2.79
52 Week Low Date
Dec 11, 2018
52 Week Price Change
-0.74
52 Week Gain
-19.68%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 14. 2016
2.48
Jan 9. 2017
3.17
16 Trading Days
27.94%
Link
LONG
Apr 26. 2017
2.50
May 12. 2017
3.32
12 Trading Days
32.72%
Link
LONG
Sep 7. 2017
3.92
Sep 21. 2017
4.38
10 Trading Days
11.80%
Link
LONG
Nov 3. 2017
4.21
Dec 1. 2017
6.62
19 Trading Days
57.33%
Link
Company Information
Stock Symbol
CDXC
Exchange
NasdaqCM
Company URL
http://www.chromadex.com
Company Phone
949-419-0288
CEO
Frank L. Jaksch
Headquarters
California
Business Address
10005 MUIRLANDS BLVD., STE. G, FIRST FLOOR, IRVINE, CA 92618
Sector
-
Industry Category
Chemicals
Industry Group
Chemicals - Major Diversified
CIK
0001386570
About

Chromadex Corp. engages in acquiring, developing, and commercializing proprietary-based ingredient technologies through its business model. It operates through the following segments: Ingredients, Core Standards and Contract Services, and Regulatory Consulting. The Ingredients segment offers developing and commercializing proprietary-based ingredient technologies. The Core Standards and Contract Services segment involves focuses on natural product fine chemicals, chemistry, and analytical testing services. The Regulatory Consulting segment offers consulting projects for customers in Europe, South, America, and Asia. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in September 1999 and is headquartered in Irvine, CA.

Description

ChromaDex Corporation, a natural products company, discovers, acquires, develops, and commercializes patented and proprietary ingredient technologies. The company offers bulk raw materials for use in dietary supplements, food, beverages, and cosmetic products; Nicotinamide riboside (NIAGEN), a vitamin found naturally in milk for enhancing cardiovascular health, glucose levels, cognitive function, and anti-aging effects; Pterostilbene (pTeroPure), a polyphenol and antioxidant used in health related fields; and Immulina, a spirulina extract and compound, which is used for improving human immune function, as well as developing Pterostilbene and caffeine co-crystal ingredients, and anthocyanins ingredients. It also provides reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. In addition, the company offers a range of contract services, including routine contract analysis for the production of dietary supplements, cosmetics, foods, and other natural products, as well as elaborate contract research for clients in these industries; and consulting services in the areas of regulatory support, new ingredient or product development, risk management, and litigation support, as well as product regulatory approval and scientific advisory services. Further, it assists customers in creating processes for manufacturing of natural products using green chemistry, as well as developing quality verification seal program, phytochemical libraries, plant extracts libraries, and databases for cross-referencing phytochemicals. The company markets and sells its products directly in the United States and Canada; and through distributors in Europe, China, Japan, South Korea, Brazil, Australia, New Zealand, Taiwan, South Africa, India, Indonesia, Malaysia, Singapore, Thailand, and Mexico. ChromaDex Corporation is based in Irvine, California.